Jesse I. Treu
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jesse I. Treu
Jesse I. Treu was last confirmed as CEO at Aldeyra Therapeutics, Inc. (ALDX) in a filing dated April 27, 2020. Earlier roles on record: Board Member at Aldeyra Therapeutics, Inc. (ALDX) until January 21, 2021.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2020-04-27
Last confirmed by a filing; no departure on record
-
Start not stated–2021-01-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
No call appearances or filed executive changes recorded yet.